Preclinical, non-genetic models of lung adenocarcinoma: a comparative survey
暂无分享,去创建一个
[1] F. López-Ríos,et al. Treating KRAS-mutant NSCLC: latest evidence and clinical consequences , 2017, Therapeutic advances in medical oncology.
[2] A. Jager,et al. Ex vivo tumor culture systems for functional drug testing and therapy response prediction , 2017, Future science OA.
[3] W. Storkus,et al. Biosynthesis and Functional Significance of Peripheral Node Addressin in Cancer-Associated TLO , 2016, Front. Immunol..
[4] Yiping Yang,et al. Cancer immunotherapy: harnessing the immune system to battle cancer. , 2015, The Journal of clinical investigation.
[5] C. Kemp,et al. Induction of Lung Tumors in Mice with Urethane. , 2015, Cold Spring Harbor protocols.
[6] Cameron Alexander,et al. In vitro co-culture model of medulloblastoma and human neural stem cells for drug delivery assessment. , 2015, Journal of biotechnology.
[7] Y. Kanai,et al. Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer , 2015, British Journal of Cancer.
[8] Georges Noel,et al. Three-Dimensional Cell Culture: A Breakthrough in Vivo , 2015, International journal of molecular sciences.
[9] L. weiswald,et al. Spherical Cancer Models in Tumor Biology1 , 2015, Neoplasia.
[10] Stefan Przyborski,et al. Advances in 3D cell culture technologies enabling tissue‐like structures to be created in vitro , 2014, Journal of anatomy.
[11] W. Peitsch,et al. Prognostic value of immune cell infiltration, tertiary lymphoid structures and PD-L1 expression in Merkel cell carcinomas. , 2014, International journal of clinical and experimental pathology.
[12] M. Cekanova,et al. Animal models and therapeutic molecular targets of cancer: utility and limitations , 2014, Drug design, development and therapy.
[13] Liju Yang,et al. Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. , 2014, Assay and drug development technologies.
[14] Wei Sun,et al. Three-dimensional in vitro cancer models: a short review , 2014, Biofabrication.
[15] P. Allavena,et al. Occurrence of Tertiary Lymphoid Tissue Is Associated with T-Cell Infiltration and Predicts Better Prognosis in Early-Stage Colorectal Cancers , 2014, Clinical Cancer Research.
[16] J. Tichelaar,et al. Mouse models of chemically-induced lung carcinogenesis. , 2013, Frontiers in bioscience.
[17] M. Nevalainen,et al. Ex vivo prostate cancer explant organ culture model system for targeted drug development in prostate cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] H. Hammad,et al. Tertiary lymphoid organs in infection and autoimmunity , 2012, Trends in Immunology.
[19] Anne Vincent-Salomon,et al. Molecular profiling of patient-derived breast cancer xenografts , 2012, Breast Cancer Research.
[20] D. Haber,et al. Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents , 2010, Nature Reviews Cancer.
[21] Dae-Hun Park,et al. Diethylnitrosamine (DEN) induces irreversible hepatocellular carcinogenesis through overexpression of G1/S-phase regulatory proteins in rat. , 2009, Toxicology letters.
[22] A. Richmond,et al. Mouse xenograft models vs GEM models for human cancer therapeutics , 2008, Disease Models & Mechanisms.
[23] M. Bibby,et al. 50 years of preclinical anticancer drug screening: empirical to target-driven approaches. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[24] R. Knuechel,et al. Distribution and subcellular localization of a water-soluble hematoporphyrin-platinum(II) complex in human bladder cancer cells. , 2004, Cancer letters.
[25] M. Bibby,et al. Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages. , 2004, European journal of cancer.
[26] T. Jacks,et al. Modeling human lung cancer in mice: similarities and shortcomings , 1999, Oncogene.
[27] E. Campo,et al. Ki‐ras gene mutations and absence of p53 gene mutations in spontaneous and urethane‐induced early lung lesions in CBA/J mice , 1998, Molecular carcinogenesis.
[28] Marshall W. Anderson,et al. Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[29] E. Casanova,et al. Modeling cancer using genetically engineered mice. , 2015, Methods in molecular biology.
[30] B. Ruggeri,et al. Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery. , 2014, Biochemical pharmacology.
[31] G. Williams,et al. N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. , 1996, Pharmacology & therapeutics.